C07K 2319/036
Targeting to the medium outside of the cell
Official title: targeting to the medium outside of the cell, e.g. type III secretion
C07K2319/036 (Targeting to the medium outside of the cell) appears on 341 US grants and 279 published applications in this corpus.
Search patents in C07K- Granted patents
- 341
- Published applications
- 279
- Assignees
- 267
- Inventors
- 884
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 6 | 0 |
| 1989 | 12 | 0 |
| 1990 | 11 | 0 |
| 1991 | 16 | 0 |
| 1992 | 17 | 0 |
| 1993 | 14 | 0 |
| 1994 | 7 | 0 |
| 1995 | 7 | 0 |
| 1996 | 17 | 0 |
| 1997 | 14 | 0 |
| 1998 | 18 | 0 |
| 1999 | 8 | 0 |
| 2000 | 8 | 0 |
| 2001 | 9 | 1 |
| 2002 | 7 | 7 |
| 2003 | 13 | 16 |
| 2004 | 4 | 6 |
| 2005 | 2 | 4 |
| 2006 | 3 | 10 |
| 2007 | 5 | 2 |
| 2008 | 1 | 6 |
| 2009 | 3 | 6 |
| 2010 | 5 | 10 |
| 2011 | 5 | 13 |
| 2012 | 6 | 9 |
| 2013 | 6 | 13 |
| 2014 | 9 | 15 |
| 2015 | 12 | 15 |
| 2016 | 9 | 8 |
| 2017 | 10 | 10 |
| 2018 | 6 | 12 |
| 2019 | 6 | 12 |
| 2020 | 7 | 17 |
| 2021 | 5 | 14 |
| 2022 | 17 | 14 |
| 2023 | 7 | 12 |
| 2024 | 10 | 22 |
| 2025 | 9 | 8 |
| 2026 | 6 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Expression of the human lekti gene from the chromosome of Staphylococcus epidermidis29 Sep 2026US 12,747,281 B2Azitra Inc
- Modified UBE3A gene for a gene therapy approach for Angelman syndrome15 Sep 2026US 12,734,250 B2University of South Florida
- Decorin compositions and use thereof8 Sep 2026US 12,729,227 B2Catalent Pharma Solutions, LLC
- Tumor necrosis factor (TNF) receptor superfamily (TNFRSF) receptor-activating antibody fusion proteins with FCγR-independent agonistic activity (TNFRSF receptor-activating antibody fusion proteins with FCγR-independent agonistic activity; TRAAFFIAA)25 Aug 2026US 12,715,928 B2Julius-Maximilians-UniversitäT WüRzburg
- Methods and compositions for treating skin disease with recombinant microorganisms11 Aug 2026US 12,702,684 B2Azitra Inc
- Methods and compositions for displaying peptide libraries8 Oct 2026US 2026/0308224 A1Board of Regents, The University of Texas System
- Method and drug for treating cancer by joint use of nkg2d chimeric antigen receptor and pd1 inhibitor27 Aug 2026US 2026/0248853 A1Daren Biotech Limited
- Methods of eliciting immuno-tolerance using soluble immune checkpoint proteins27 Aug 2026US 2026/0250716 A1Duke University
- Compositions and methods for producing heterologous globins in filamentous fungal cells6 Aug 2026US 2026/0226401 A1Danisco US Inc.
- Immunogenic compositions and methods of inducing an immune response against varicella zoster virus30 Jul 2026US 2026/0216319 A1Pfizer Inc.
Most cited
By later US patents
- Single polypeptide chain binding molecules2,454US 4,946,778 AGenex Corporation · 1990
- Modular assembly of antibody genes, antibodies prepared thereby and use298US 5,618,920 AXoma Corporation · 1997
- Modular assembly of antibody genes, antibodies prepared thereby and use250US 6,204,023 B1Xoma Corporation · 2001
- Fusion proteins comprising GM-CSF and IL-3245US 5,073,627 AImmunex Corporation · 1991
- Synthetic plant genes242US 5,500,365 AMonsanto Company · 1996